A North Carolina-based biotech company is seeing some premarket action on Tuesday after the company announced the final results from the Phase 2 VIBRANT study of vurolenatide in...

To read the full story on AllPennyStocks.com, click here.

9 Meters Biopharma (NASDAQ:NMTR)
過去 株価チャート
から 5 2024 まで 6 2024 9 Meters Biopharmaのチャートをもっと見るにはこちらをクリック
9 Meters Biopharma (NASDAQ:NMTR)
過去 株価チャート
から 6 2023 まで 6 2024 9 Meters Biopharmaのチャートをもっと見るにはこちらをクリック